COVID-19, caused by SARS-CoV-2, continues to be a major health problem since its first description in Wuhan, China, in December 2019. Multiple drugs have been tried to date in the treatment of COVID-19. Critical to treatment ...

By the end of February 2021, roughly 115 million people worldwide had been infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and more than 2.5 million had died. Uneasily, the coronavirus disease ...

The arrival of coronavirus disease (COVID-19) in Europe exploded initially in North Italy and soon thereafter at several other major European cities, including Madrid. Indeed, Madrid was the epicenter of SARSCoV- 2 infection ...

BACKGROUND: Hepatitis delta is the most aggressive form of chronic viral hepatitis. We examined the clinical burden, epidemiological features and time trends for hepatitis delta patients hospitalized in Spain during the ...

Across human societies, a fraction of men and women (around 2-10%) report engaging in sex with samesex partners, either exclusively or, more frequently, in addition to having heterosexual partners (bisexuals) (ACSF. Nature ...

The medical demand imposed by COVID-19 has distracted proper care of other illnesses. Herein, we report the impact on new diagnoses of HTLV-1, HTLV-2, and HIV-2 in Spain, where these infections are mostly driven by immigration ...

Background: The advent of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines has been associated with a significant decline in coronavirus disease 2019 (COVID-19) hospitalizations and deaths. However, ...

Envisioning a hepatitis delta cure with new antivirals

The opioid epidemic is a tragedy in the United States. In the 12-month period that ended in April 2021, more than 100,000 US citizens died of drug overdose, up almost 30% from the 78,000 deaths in the prior year.

Up to date, a sterilizing cure of HIV-1 infection has been reported in only two persons living with HIV-1 who underwent allogeneic hematopoietic stem cell transplantations from donors who were homozygous for the CCR5 Δ32 ...